Lyconadins D and E, and complanadine E, new Lycopodium alkaloids from Lycopodium complanatum

Bioorganic and Medicinal Chemistry

Volumn 19, Issue 2, 2011, Pages 749-753

  Ishiuchi, Kan'Ichiro ^a   Kubota, Takaaki ^a   Ishiyama, Haruaki ^a   Hayashi, Shigeki ^b   Shibata, Toshiro ^b   Mori, Koichiro ^c   Obara, Yutaro ^c   Nakahata, Norimichi ^c   Kobayashi, Jun'Ichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Complanadine E; Lyconadin D; Lyconadin E; Lycopodium alkaloids; Lycopodium complanatum

Indexed keywords

ALKALOID; COMPLANADINE A; COMPLANADINE B; COMPLANADINE D; COMPLANADINE E; LYCONADIN D; LYCONADIN E; MESSENGER RNA; NERVE GROWTH FACTOR; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA CELL; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ISOLATION; DRUG STRUCTURE; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR MULTIPLE QUANTUM COHERENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LYCOPODIUM COMPLANATUM; MEDICINAL PLANT; NUCLEAR OVERHAUSER EFFECT; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY;

ALKALOIDS; CELL LINE, TUMOR; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; LYCOPODIUM; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; NERVE GROWTH FACTOR; RNA, MESSENGER;

LYCOPODIOPHYTA; LYCOPODIUM; LYCOPODIUM COMPLANATUM;

EID: 78651481665     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.12.025     Document Type: Article

References (20)

1. For reviews of the Lycopodium alkaloids, see: Y. Hirasawa, J. Kobayashi, and H. Morita Heterocycles 77 2009 679
2. J. Kobayashi, and H. Morita G.A. Cordell, The Alkaloids Vol. 61 2005 Academic Press New York p 1, and references cited therein.
3. X. Ma, and D.R. Gang Nat. Prod. Rep. 21 2004 752
4. T. Hemscheidt, and I.D. Spenser J. Am. Chem. Soc. 118 1996 1799
5. T. Hemscheidt, and I.D. Spenser J. Am. Chem. Soc. 115 1993 3020
6. B.B. Liau, and M.D. Shair J. Am. Chem. Soc. 132 2010 9594
7. D.F. Fischer, and R. Sarpong J. Am. Chem. Soc. 132 2010 5926
8. C. Yuan, C.-T. Chang, A. Axelrod, and D. Siegel J. Am. Chem. Soc. 132 2010 5924 and references cited therein
9. J.-S. Liu, Y.-L. Zhu, C.-M. Yu, Y.-Z. Zhou, Y.-Y. Han, F.-W. Wu, and B.-F. Qi Can. J. Chem. 64 1986 837
10. K. Ishiuchi, T. Kubota, H. Ishiyama, S. Hayashi, T. Shibata, and J. Kobayashi Tetrahedron Lett. 52 2011 289
11. K. Ishiuchi, T. Kubota, S. Hayashi, T. Shibata, and J. Kobayashi Tetrahedron Lett. 50 2009 6534
12. R.V. Gerard, D.B. MacLean, R. Fagianni, and C.J. Lock Can. J. Chem. 64 1986 943
13. F.A.L. Anet, and C.R. Eves Can. J. Chem. 36 1958 902
14. F.A.L. Anet, and M.V. Rao Tetrahedron Lett. 1 1960 9
15. J. Kobayashi, Y. Hirasawa, N. Yoshida, and H. Morita Tetrahedron Lett. 41 2000 9069
16. H. Morita, K. Ishiuchi, A. Haganuma, T. Hoshino, Y. Obara, N. Nakahata, and J. Kobayashi Tetrahedron 61 2005 1955
17. K. Ishiuchi, T. Kubota, Y. Mikami, Y. Obara, N. Nakahata, and J. Kobayashi Bioorg. Med. Chem. 15 2007 413
18. Y. Obara, H. Kobayashi, T. Ohta, Y. Ohizumi, and N. Nakahata Mol. Pharmacol. 59 2001 1287
19. K. Mori, Y. Obara, M. Hirota, Y. Azumi, S. Kinugasa, S. Inatomi, and N. Nakahata Biol. Pharm. Bull. 31 2008 1727
20. These cross-peaks corresponded to H-9a/C-9 and H-6/C-6 of 1, respectively.